If you enjoy this content, please share it with a colleague
RELATED CONTENT
April 24, 2017 — Cancer Targeted Technology recently announced it is focusing on small molecules that target pivotal ...
At the surface, the term “advanced visualization” seems nebulous at best. Medical imaging technology continues to develop and advance at a rapid rate, so determining what qualifies as advanced remains a moving target as well. In general, however, the current cutting edge of imaging centers around 3-D/4-D viewing and mobile technology, with different specialties implementing them in unique ways.Â
Cancer Targeted Technology (CTT), announced that it was awarded a NIH two-year, $2 million Small Business Innovation Research (SBIR) grant. The funds will be used to develop a new agent that will help diagnose and monitor metastatic prostate cancer.